Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_842Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoNAEpithelial ovarian carcinomaSKOV33.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.01 MOI35% cancer cell killingNoNoNA No responseNANANANA10770637
OV_843Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaOVCAR33.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.01 MOI35% cancer cell killingNoNoNA No responseNANANANA10770637
OV_844Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaCaOV33.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.01 MOI35% cancer cell killingNoNoNA No responseNANANANA10770637
OV_845Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27803.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.01 MOI35% cancer cell killingNoNoNA No responseNANANANA10770637
OV_846Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27813.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.1 MOI75% cancer cell killingNoNoNA No responseNANANANA10770637
OV_847Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27823.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.1 MOI75% cancer cell killingNoNoNA No responseNANANANA10770637
OV_848Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27833.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.1 MOI75% cancer cell killingNoNoNA No responseNANANANA10770637
OV_849Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27843.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay0.1 MOI75% cancer cell killingNoNoNA No responseNANANANA10770637
OV_850Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27843.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay1 MOI98% cancer cell killingNoNoNA No responseNANANANA10770637
OV_851Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27843.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay1 MOI98% cancer cell killingNoNoNA No responseNANANANA10770637
OV_852Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27843.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay1 MOI98% cancer cell killingNoNoNA No responseNANANANA10770637
OV_853Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCEpithelial ovarian carcinomaA27843.0E+3 cells per wellMinimal cytotoxic to mesothelial cellsBeta galacosidase colorimetric proliferation assay1 MOI98% cancer cell killingNoNoNA No responseNANANANA10770637
OV_854Herpes simplex virusHSV-G207DNAHerpesviridaeDeletion mutant in ICP34.5 and ICPC6 geneYesNoNoATCCNANANANANANANAFemale CB17 SCID mice model xenograft for SKOV3 cell5.0E+6 pfuNA Reduction in tumor growth to 50mg compared to control of 300mg within weekNANANANA10770637
OV_860Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay1 MOI94% cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_861Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay1 MOI75 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_862Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay1 MOI80 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_863Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay1 MOI99% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_864Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay1 MOI92% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_865Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay1 MOI96% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_866Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay0.1 MOI60% cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_867Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay0.1 MOI40 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_868Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay0.1 MOI60 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_869Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay0.1 MOI95% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_870Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay0.1 MOI80% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_871Herpes simplex virusBL1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay0.1 MOI80% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_872Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay1 MOI94% cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_873Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay1 MOI85 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_874Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay1 MOI85 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_875Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay1 MOI98% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_876Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay1 MOI96% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_877Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay1 MOI97% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_878Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay0.1 MOI60% cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_879Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay0.1 MOI60 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_880Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay0.1 MOI60 % cancerous cell killing after 24 hoursNoNoNA No responseNANANANA12595888
OV_881Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCCellosaurus cell lineSK-MEL-28NANAMTT assay0.1 MOI95% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_882Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCTriple-negative breast cancer cell lineMDA-MB-231NANAMTT assay0.1 MOI88% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_883Herpes simplex virusJS1DNAHerpesviridaeNoneYesNoNoATCCHuman colorectal adenocarcinoma cell lineHT-29NANAMTT assay0.1 MOI88% cancerous cell killing after 48 hoursNoNoNA No responseNANANANA12595888
OV_884Herpes simplex virusJS1DNAHerpesviridaeJS1 strain mutant in ICP34.5 and ICP47YesNoNoATCCNANANANAMTT assayNANABALB/c nude mice xenograft for HT-29 cell1.0E+8 pfu NA Compelte reduction of tumor after 28 daysintraperitonialNAIncrease production of IFN-gammaNA12595888
OV_885Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml75% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_886Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml85% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_887Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml85% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_888Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml95% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_889Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml90% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_890Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.1 pfu/ml95% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_891Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml70% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_892Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml75% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_893Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 24 hoursNoNoNA No responseNANANANA12788648
OV_894Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHepatocellular carcinoma cell lineHep3B3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml99% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_895Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCGlioblastoma cell lineU-87 MG3.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_896Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCHuman prostate cancer cell lineDu1453.0E+4 cells per wellNATrypan blue staining and hematocytometer0.01 pfu/ml80% cncer cell killing after 48 hoursNoNoNA No responseNANANANA12788648
OV_897Herpes simplex virusMutantDNAHerpesviridaeDeletion mutant for Gamma 34.5YesNoNoATCCNANANANANANANAHsd athymic nude mice xenograft for Hep 3B cancer cell line1.0E+7 pfu NA Complete reduction in tumor nodes after 4 weeksintraperitonialNANANA12788648
OV_898Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell2% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_899Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_900Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_901Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_902Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell40% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_903Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_904Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_905Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_906Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell90% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_907Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_908Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell30% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_909Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_910Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_911Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_912Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_913Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_914Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_915Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_916Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice orthotopic xenograft for prostate cancer cell line2.0E+7 pfu NA 30% reduction in tumor volumeTail vein injection of virusNANANA15129429
OV_917Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice orthotopic xenograft for prostate cancer cell line2.0E+7 pfu NA 50% reduction in tumor volumeTail vein injection of virusNANANA15129429
OV_918Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice orthotopic xenograft for prostate cancer cell line2.0E+7 pfu NA 60% reduction in tumor volumeTail vein injection of virusNANANA15129429
OV_919Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice metastatic lung metastatic model2.0E+7 pfu NA Lung metastasis were not detected after 40 days when stained with bouins fixativeTail vein injection of virusNANANA15129429
OV_920Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice metastatic lung metastatic model2.0E+7 pfu NA Lung metastasis were not detected after 40 days when stained with bouins fixativeTail vein injection of virusNANANA15129429
OV_921Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCNANANANANANANABALB/cByJIcrSmnHsd-scid mice metastatic lung metastatic model2.0E+7 pfu NA Lung metastasis were not detected after 40 days when stained with bouins fixativeTail vein injection of virusNANANA15129429
OV_991Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_992Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_993Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell80% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_994Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell60% cell kills after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_995Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell90% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_996Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell50% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_997Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell20% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_998Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_999Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell60% cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1000Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1001Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1002Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1003Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 pfu/cell10% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1004Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1005Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1006Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 pfu/cell100% cell kills after 8 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1007Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1008Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1009Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 pfu/cell100% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1010Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 pfu/cell90% cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1011Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 pfu/cell100% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1012Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 pfu/cell100% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1013Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 pfu/cell90% cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1014Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 pfu/cell50% cell kills after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1015Herpes simplex virusHSV-1DNAHerpesviridaeMutant NV1066YesNoNoMediGene Inc. San Diego, CANeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 pfu/cell100% cell survivalk after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577